Bacchiocchi Antonella, Mak Michael, Khan Zerin Mahzabin, Gong Xiangyu, Sznol Mario, Na Zhenkun, Su Haomiao, Chan Lok Hei, Yan Qin, Zhao Dejian, Mortlock Ryland D, Knight James, Slavoff Sarah A, Halaban Ruth
Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.
Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.
Oncogene. 2025 Aug 30. doi: 10.1038/s41388-025-03538-2.
Leucine zipper like transcription regulator 1 (LZTR1) is amplified in acral melanomas, is required for melanocytes and melanoma cell proliferation, and it induces anchorage-independent growth, by yet unknown mechanisms. We therefore performed comprehensive studies to identify its activity in melanomas employing proximity biotinylation and co-immunoprecipitation combined with LC-MS/MS proteomics and molecular characterization. The results show that LZTR1 regulates the ubiquitin proteasome system in melanoma cells and also associates with actin-related proteins and actin cytoskeleton organization. Its downregulation suppresses the protective effect of the autophagy-initiating ULK1 and AMBRA1, regulators of normal cell survival and proliferation, and upregulates the sequestosome 1 (SQSTM1/p62), an autophagic cargo adapter which mediates selective degradation of ubiquitinated proteins. In contrast, overexpression of LZTR1 provides growth advantage under environmental stress, enhancing cell invasion, by activating ERBB3 receptor and its downstream targets PYK2 and SRC tyrosine kinases that regulate the cytoskeleton, actin organization, cell spreading, cell migration and adhesion. LZTR1 is a "safeguard" for melanoma cells under stress and its downregulation can be exploited for melanoma therapy.
亮氨酸拉链样转录调节因子1(LZTR1)在肢端黑色素瘤中扩增,是黑素细胞和黑色素瘤细胞增殖所必需的,并且通过尚不清楚的机制诱导不依赖贴壁生长。因此,我们进行了全面的研究,采用邻近生物素化和免疫共沉淀结合液相色谱-串联质谱蛋白质组学和分子表征来确定其在黑色素瘤中的活性。结果表明,LZTR1调节黑色素瘤细胞中的泛素蛋白酶体系统,还与肌动蛋白相关蛋白和肌动蛋白细胞骨架组织相关联。其下调会抑制自噬起始因子ULK1和AMBRA1的保护作用,ULK1和AMBRA1是正常细胞存活和增殖的调节因子,并且会上调隔离小体1(SQSTM1/p62),一种自噬货物衔接蛋白,介导泛素化蛋白的选择性降解。相反,LZTR1的过表达在环境应激下提供生长优势,通过激活ERBB3受体及其下游靶点PYK2和SRC酪氨酸激酶来增强细胞侵袭,这些激酶调节细胞骨架、肌动蛋白组织、细胞铺展、细胞迁移和黏附。LZTR1是应激状态下黑色素瘤细胞的“保护者”,其下调可用于黑色素瘤治疗。
1993
Cochrane Database Syst Rev. 2018-2-6
Transl Lung Cancer Res. 2025-2-28
iScience. 2024-3-26
Sci Rep. 2023-9-25